Bibliographie HappyVisc

Baron D, Baron H, Baerer C et al. Predictors for patient satisfaction of a single intra-articular injection of crosslinked hyaluronic acid combined with mannitol (HANOX-M-XL) in patients with temporomandibular joint osteoarthritis. Results of a prospective open-label pilot study (HAPPYMINI-ARTEMIS trial). BMC Musculoskelet Disord. 2022 ;23(1):392. doi: 10.1186/s12891-022-05352-3.

Galois L, Coillard JY, Porterie J, et al. Open-Label Pilot Study of a Single Intra-Articular Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid (HANOX-M-XL) for the Treatment of the First Metatarsophalangeal Osteoarthritis (Hallux Rigidus): The REPAR Trial. Clin Med Insights Arthritis Musculoskelet Disord. 2022;15:11795441211055882. doi: 10.1177/11795441211055882.

Dauvissat J, Rizzo C, Lellouche H, et al. Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial). Clin Med Insights Arthritis Musculoskelet Disord. 2018;11:1179544118782901. doi: 10.1177/1179544118782901.